relative to insurance coverage for biomarker testing.

Latest action: Subcommittee Work Session: 09/09/2026 10:00 am GP 229

Voted 8/21/2026View source

Roll-call record

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.

Docket history

5/14/2026Refer for Interim Study: MA VV 05/14/2026 HJ 13 P. 9
5/1/2026Committee Report: Refer for Interim Study 04/29/2026 (Vote 15-0; CC) HC 19 P. 8
4/22/2026Subcommittee Work Session: 04/28/2026 10:00 am GP 229
4/22/2026Executive Session: 04/29/2026 10:00 am GP 229
4/16/2026Subcommittee Work Session: 04/22/2026 10:00 am GP 229
4/1/2026Subcommittee Work Session: 04/08/2026 10:00 am GP 229
3/24/2026Public Hearing: 04/01/2026 11:00 am GP 229
3/16/2026Introduced (in recess of) 03/12/2026 and referred to Commerce and Consumer Affairs HJ 8 P. 114
3/16/2026Introduced (in recess of) 03/12/2026 and referred to Commerce and Consumer Affairs HJ 8
3/6/2026Ought to Pass: MA, VV; OT3rdg; 03/12/2026; SJ 6